PetMed Express (NASDAQ:PETS) Share Price Passes Above Two Hundred Day Moving Average - Should You Sell?

PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $4.20 and traded as high as $5.29. PetMed Express shares last traded at $5.17, with a volume of 190,844 shares.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of PetMed Express from a "hold" rating to a "buy" rating in a research note on Tuesday, November 12th.

PetMed Express Stock Performance

The business has a 50-day moving average of $5.06 and a 200-day moving average of $4.20. The stock has a market capitalization of $103.61 million, a price-to-earnings ratio of -83.58 and a beta of 0.69.

PetMed Express (NASDAQ:PETS - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of ($0.06) by $0.17. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. The firm had revenue of $59.57 million for the quarter, compared to analyst estimates of $66.02 million. Equities analysts predict that PetMed Express, Inc. will post 0.24 earnings per share for the current fiscal year.

Insider Activity

In other PetMed Express news, Director Leslie C.G. Campbell bought 15,000 shares of PetMed Express stock in a transaction that occurred on Wednesday, December 4th. The shares were purchased at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the completion of the transaction, the director now owns 70,000 shares of the company's stock, valued at $376,600. This represents a 27.27 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.10% of the company's stock.

Institutional Investors Weigh In On PetMed Express

A number of institutional investors have recently added to or reduced their stakes in PETS. Sei Investments Co. boosted its stake in shares of PetMed Express by 8.3% during the 2nd quarter. Sei Investments Co. now owns 44,220 shares of the company's stock valued at $179,000 after buying an additional 3,400 shares during the last quarter. Point72 DIFC Ltd bought a new stake in PetMed Express during the second quarter valued at $34,000. Marshall Wace LLP acquired a new stake in shares of PetMed Express during the second quarter worth $46,000. Independent Advisor Alliance bought a new position in PetMed Express in the third quarter worth about $106,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in PetMed Express during the 2nd quarter worth $135,000. Hedge funds and other institutional investors own 73.33% of the company's stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.